Shirley Beguin

CYP2C19*2 and *17 Alleles Have a Significant Impact on Platelet Response and Bleeding Risk in Patients Treated With Prasugrel After Acute Coronary Syndrome

Thomas Cuisset, Marie Loosveld, Pierre‐Emmanuel Morange et al. · JACC: Cardiovascular Interventions · 2012 · 102 citations

Thrombosis, Cardiovascular Disease, Platelet Response +12

Clinical Implications of Very Low On-Treatment Platelet Reactivity in Patients Treated With Thienopyridine

Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou et al. · JACC: Cardiovascular Interventions · 2013 · 75 citations

Thrombopoiesis, Thrombosis, Clinical Implications +7

Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications

Charlotte Grosdidier, Jacques Quilici, Marie Loosveld et al. · The American Journal of Cardiology · 2013 · 69 citations

Thrombopoiesis, Thrombosis, Bleeding Complications +12

Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy

Thomas Cuisset, Bénédicte Gaborit, Noémie Dubois et al. · International Journal of Cardiology · 2012 · 28 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12